Treatment with HDAC inhibitor has been previously found to decrease EGFR mRNA and promoter activity by dissociation of transcription factor SP1 from the EGFR promoter around the transcription start site of EGFR gene in colorectal cancer cells [30]. This evidence concerns the gene SP1 and colorectal cancer.